ADAR1 Partners, LP, 10% Owner at Keros Therapeutics, Inc. (KROS), bought 1,008,591 shares at $10.33 ($10.2M) on 2025-04-09, disclosed to the SEC on 2025-04-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.40 | 16,365 | $154K | 1.5% |
| 2 | $9.40 | 18,560 | $174K | 1.7% |
| 3 | $9.86 | 325,000 | $3.2M | 31.3% |
| 4 | $10.33 | 74,333 | $768K | 7.5% |
| 5 | $10.33 | 74,333 | $768K | 7.5% |
| 6 | $10.33 | 500,000 |
| $5.2M |
| 50.5% |
| Total | $10.15 avg | 1,008,591 | $10.2M | 100% |